Evidence map›Paper›PMID 28455529›Full record

ArticleScientific reports2017

Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation.

Yijia Wang, Chunze Zhang, Shiwu Zhang, Zhenying Zhao, Jiawen Wang, Jiali Song, Yue Wang, Jun Liu, Shaobin Hou

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Frontiers in pharmacology · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Inhibitory activity of medicinal mushroomPrecision clinical medicine · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yijia WangTianjin Union Medical Center, Tianjin, 300121, China.
Chunze ZhangTianjin Union Medical Center, Tianjin, 300121, China.
Shiwu ZhangTianjin Union Medical Center, Tianjin, 300121, China.
Zhenying ZhaoTianjin Union Medical Center, Tianjin, 300121, China.
Jiawen WangTianjin Union Medical Center, Tianjin, 300121, China.
Jiali SongTianjin Union Medical Center, Tianjin, 300121, China.
Yue WangTianjin Union Medical Center, Tianjin, 300121, China.
Jun LiuTianjin Union Medical Center, Tianjin, 300121, China. junliu_sci@163.com.
Shaobin HouAdvanced Studies in Genomics, Proteomics, and Bioinformatics, University of Hawaii at Manoa 2538 McCarthy Mall, Snyder Hall, Honolulu, HI, 96822, USA. shaobin@hawaii.edu.
Tianjin People's Hospital · CNUniversity of Hawaiʻi at Mānoa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taxol, a first-line anti-tumour drug, has low effectiveness against colorectal cancer. Combination with other agents is an effective strategy to enhance Taxol cytotoxicity. Kanglaite injection is an extract from Coix lacryma-jobi seed and is usually combined with other agents to treat cancer. The aim of this study was to investigate the treatment effect of Taxol combined with Kanglaite on colorectal cancer cell lines. Kanglaite pretreatment followed by Taxol treatment was found to show the best synergism among all combination strategies. This combination also resulted in the smallest tumour volume in a Balb/c mice model. Kanglaite inhibited the expression of nuclear factor (NF)-κΒ and upregulated that of connexin 43, both of which sensitized cancer cells to Taxol. Moreover, Kanglaite increased many cellular variations caused by Taxol, including tubulin polymerization, caspase-3 cleavage, and upregulated expression of survivin and cyclin B1. These results suggest that Kanglaite pretreatment may increase the effect of Taxol on colorectal cancer.

Indexed as

Drug SynergismAnimalsAntineoplastic Agents, PhytogenicCell Line, TumorColorectal NeoplasmsConnexin 43Disease Models, AnimalDrugs, Chinese HerbalMice, Inbred BALB CNF-kappa BPaclitaxelTreatment OutcomeUp-RegulationAntineoplastic Agents, PhytogenicConnexin 43Drugs, Chinese Herbalkang-lai-teNF-kappa BPaclitaxel

Identifiers

PMID28455529
PMCPMC5430786
OpenAlexW2609537225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.